Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Pulmicort for acute adult asthma attack
IRCT20170325033132N3Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Pulmicort plus standard treatment with Placebo nebulized normal saline plus standard treatment (2 arms). Primary endpoints: Recovery of clinical symptoms of acute asthma, Recurrence rate and 1 more. Started Mar 2016; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20170325033132N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170325033132N3.